- Tous > Medicine Access and Rational Use > Antimicrobial Drug Resistance
- Tous > Medicine Access and Rational Use > Rational Use
- Mots-clés > antimicrobial resistance (AMR)
- Mots-clés > appropriate use
- Mots-clés > Drug and Therapeutics Committee - DTC
- Mots-clés > drug use
- Mots-clés > drug use evaluation
- Mots-clés > health facility surveys
- Mots-clés > medicines use - patterns and trends
- Mots-clés > primary health facilities
- Mots-clés > rational medicine use (RMU)
- Mots-clés > use of medicines
(2009; 45 pages)
This medicine use study was planned, conducted, and analyzed by MSH’s SPS Program in collaboration with the Ministry of Public Health (MoPH). Data collection for the study was conducted in March and April 2009. Preliminary results were presented at the Afghanistan Drug and Therapeutics Committee (DTC) Training Course in July 2009, and final analysis and reporting was completed in December 2009.
Afghanistan possesses strong support for rational medicine use (RMU) through the development of the Basic Package of Health Services (BPHS) for Afghanistan, the Essential Package of Hospital Services (EPHS) for Afghanistan, Essential Drugs List (EDL), licensed drug list (LDL), National Drug and Therapeutics Committee, and numerous policies and procedures that address RMU. The U.S. Agency for International Development and other donors have provided support for implementing interventions to address RMU in Afghanistan.
The outcomes of this study show a number of concerns and problems in the use of medicines in Afghanistan. They also show that there are some very positive results and activities currently going on throughout Afghanistan that contribute to RMU.